Covert hepatic encephalopathy: a neglected topic—a narrative review

IF 0.8 Q4 GASTROENTEROLOGY & HEPATOLOGY Egyptian Liver Journal Pub Date : 2024-07-18 DOI:10.1186/s43066-024-00364-1
Mohamed Elbadry, Amin Abdel Baki, Asmaa bakr, Eman A. Elhamrawy, Hayam Abdel-Tawab, Abdelghany Aish, Israa Nooh, Abdulmoneim Adel, Moataz Y. Soliman, Nessren Mohammed, Samy Zaky
{"title":"Covert hepatic encephalopathy: a neglected topic—a narrative review","authors":"Mohamed Elbadry, Amin Abdel Baki, Asmaa bakr, Eman A. Elhamrawy, Hayam Abdel-Tawab, Abdelghany Aish, Israa Nooh, Abdulmoneim Adel, Moataz Y. Soliman, Nessren Mohammed, Samy Zaky","doi":"10.1186/s43066-024-00364-1","DOIUrl":null,"url":null,"abstract":"Covert hepatic encephalopathy (CHE) is a form of cerebral dysfunction that affects 30–40% of patients with liver cirrhosis as a grave sequel of disease progression. Although being a silent condition, yet; CHE has been reported as seriously predictive for the development of overt hepatic encephalopathy. Covert hepatic encephalopathy is said to conclude grades (0 and 1) hepatic encephalopathy in West Heaven grading of hepatic encephalopathy, hence; inferring to discrete deficits in attention, cognition, and motor control, strongly associated with poorer quality of private and social aspects of the patients’ life. Clinical recognition of cases of CHE is such a tedious task that unluckily devoid of discernment. Worthwhile; the battery of neuropsychometric tests widely known as the only tool to identify CHE can give abnormal results without specifying the cause of brain dysfunction Therefore, dedicated history-taking and clinical evaluation of liver cirrhosis patients are still the cornerstones that should unify other diagnostic tools to identify those patients at risk of developing overt hepatic encephalopathy. Diagnosis of CHE is challenging and often neglected in clinical practice, so the aim of this review is to improve our approach to CHE and begin a unified effort for the advancement of CHE through studying easy, fast, and reliable psychometric diagnostic tests to meet our clinical needs.","PeriodicalId":11620,"journal":{"name":"Egyptian Liver Journal","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Liver Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43066-024-00364-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Covert hepatic encephalopathy (CHE) is a form of cerebral dysfunction that affects 30–40% of patients with liver cirrhosis as a grave sequel of disease progression. Although being a silent condition, yet; CHE has been reported as seriously predictive for the development of overt hepatic encephalopathy. Covert hepatic encephalopathy is said to conclude grades (0 and 1) hepatic encephalopathy in West Heaven grading of hepatic encephalopathy, hence; inferring to discrete deficits in attention, cognition, and motor control, strongly associated with poorer quality of private and social aspects of the patients’ life. Clinical recognition of cases of CHE is such a tedious task that unluckily devoid of discernment. Worthwhile; the battery of neuropsychometric tests widely known as the only tool to identify CHE can give abnormal results without specifying the cause of brain dysfunction Therefore, dedicated history-taking and clinical evaluation of liver cirrhosis patients are still the cornerstones that should unify other diagnostic tools to identify those patients at risk of developing overt hepatic encephalopathy. Diagnosis of CHE is challenging and often neglected in clinical practice, so the aim of this review is to improve our approach to CHE and begin a unified effort for the advancement of CHE through studying easy, fast, and reliable psychometric diagnostic tests to meet our clinical needs.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
隐匿性肝性脑病:一个被忽视的话题--叙述性综述
隐匿性肝性脑病(CHE)是一种脑功能障碍,30%-40% 的肝硬化患者会出现这种症状,这是疾病发展的严重后遗症。虽然隐匿性肝性脑病是一种无声的病症,但据报道,隐匿性肝性脑病对显性肝性脑病的发展有严重的预示作用。在西天堂肝性脑病分级中,隐性肝性脑病被认为是肝性脑病分级(0 级和 1 级)的结论,因此可推断出患者在注意力、认知和运动控制方面存在离散性缺陷,这与患者私人生活和社会生活质量较差密切相关。临床识别 CHE 病例是一项繁琐的工作,但不幸的是却缺乏辨别能力。因此,对肝硬化患者进行专门的病史采集和临床评估仍然是统一其他诊断工具的基石,以识别那些有可能发展为明显肝性脑病的患者。肝性脑病的诊断具有挑战性,在临床实践中常常被忽视,因此本综述旨在通过研究简便、快速、可靠的心理测量诊断测试来满足临床需求,从而改进我们对肝性脑病的诊断方法,并开始为促进肝性脑病的发展做出统一的努力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Egyptian Liver Journal
Egyptian Liver Journal Medicine-Hepatology
CiteScore
1.60
自引率
0.00%
发文量
60
审稿时长
9 weeks
期刊最新文献
Effect of probiotic, prebiotic, and synbiotic supplementation on circadian clock in rats with fructose-induced non-alcoholic fatty liver Generic sofosbuvir and daclatasvir for treatment of hepatitis C virus infection in patients with sickle cell disease Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review Simultaneous choledochal cyst excision and pancreaticojejunostomy (Puestow’s technique) for type IA cyst with associated chronic pancreatitis: a case report Enormous ectopic liver tissue at the gastrohepatic ligament: a rare entity at Muhimbili National Hospital, Tanzania
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1